mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
Z-LLNle-CHO |
GDSC1000 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |